PROLOR Biotech, Inc.
Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Operating income | −$68.5M | −$14.8M | −$7.7M |
| Net income | −$67.9M | −$15.1M | −$7.6M |
| Total assets | $35.9M | $15.0M | $26.8M |
| Total liabilities | — | — | — |
| Equity | $33.2M | $12.5M | $25.0M |
| EPS (diluted) | — | — | — |
| Shares out. | 54.8M | 54.6M | 54.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- —
- Net margin
- —
- Return on equity
- −204.6%
- Return on assets
- −189.1%
- Return on capital (ROCE)
- −203.9%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.61
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Accruals / assets
- −48.8%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 1 good- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Amended charter or bylawsAug 30, 2013
- Other material eventJul 3, 2013
- Regulation FD disclosureJun 17, 2013
- Director / officer change · Shareholder voteJun 7, 2013
- Other material eventJun 4, 2013
- Entered a material agreementApr 29, 2013
- Other material eventApr 24, 2013
- Director / officer changeFeb 8, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15-12BSep 26, 2013
- EFFECTSep 9, 2013
- SC 13D/ASep 9, 2013
- S-8 POSSep 6, 2013
- S-8 POSSep 6, 2013
- POS AMSep 6, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 4OWNERSHIP DOCUMENTSep 3, 2013
- 8-KAug 30, 2013
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.